In the landscape of modern medicine, the battle against bacterial infections remains a primary concern for healthcare providers worldwide. Among the arsenal of antimicrobial agents, cephalosporins stand as one of the most widely prescribed classes of antibiotics. Within this class, (a brand name often associated with the active ingredient Cefuroxime Axetil ) represents a significant advancement.
A common clinical dilemma involves patients with a penicillin allergy. Historically, it was believed that 10% of penicillin-allergic patients would react to cephalosporins. However, modern data suggests the cross-reactivity rate is significantly lower (around 1-3%), particularly with second-generation agents like Acrocef. Nevertheless, patients with a history of to penicillin should generally avoid Acrocef or undergo skin testing/specialist consultation first. acrocef
